default author photo

Elisabetta Abruzzese

University of Rome Tor Vergata

SCHOLARLY PAPERS

1

DOWNLOADS

61

TOTAL CITATIONS

0

Scholarly Papers (1)

1.

Cytopenias and Large Splenomegaly are Main Drivers of Poor Outcome after Discontinuation of Ruxolitinib in Chronic Phase Myelofibrosis

Number of pages: 26 Posted: 07 Feb 2025
Universitaria di Bologna - Azienda Ospedaliero, Sapienza University - Hematology, Department of Translational and Precision Medicine, affiliation not provided to SSRN, Ospedale San Gerardo, affiliation not provided to SSRN, University of Udine, affiliation not provided to SSRN, University of Brescia, affiliation not provided to SSRN, University of Naples Federico II, affiliation not provided to SSRN, University of Parma, University of Padua, University of Ferrara, University of Rome Tor Vergata, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, IRCCS Ospedale Policlinico San Martino, affiliation not provided to SSRN, University of Siena, Hannover Medical School, University of Verona, affiliation not provided to SSRN and affiliation not provided to SSRN
Downloads 61 (980,173)

Abstract:

Loading...

Cytopenia, Ruxolitinib, Myelofibrosis, Splenomegaly